reviewLeukemiaJan 22, 2004Closed access

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

LSLinda S. SteelmanSCSteven C. PohnertJGJ G SheltonRARichard A. FranklinFEF. E. Bertrand

East Carolina University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

686
total citations
FWCI
18.52
Percentile
100%
References
475
Citations per year

Authors

6

Topics & keywords

Topics
Keywords
  • MAPK/ERK pathway
  • Cancer research
  • Protein kinase B
  • Geldanamycin
  • Imatinib mesylate
  • PI3K/AKT/mTOR pathway
  • Signal transduction
  • Biology
No related works found for this paper.